Table I.
Diagnoses/Phenotypes | Classified as DSD | |
---|---|---|
n | % | |
45,X/46,XY MGD, ovotestes | 22 | 100 |
46,XX/46,XY chimera, ovotestes | 22 | 100 |
Ovotestes | 22 | 100 |
46,XX with male phenotype | 22 | 100 |
Androgen biosynthesis defect (e.g., 5α reductase deficiency) | 22 | 100 |
Androgen excess in 46,XX due to fetal (e.g., 21-hydroxylase deficiency), fetoplacental (e.g., aromatase deficiency), or maternal (e.g., luteoma) causes | 22 | 100 |
Defect in androgen action (e.g., complete androgen insensitivity syndrome (CAIS); partial androgen insensitivity syndrome (PAIS)) | 22 | 100 |
Complete gonadal dysgenesis | 22 | 100 |
Partial gonadal dysgenesis | 22 | 100 |
Disorders of AMH and AMH receptor (persistent Müllerian duct syndrome) | 20 | 91 |
LH receptor defects (e.g., Leydig cell hypoplasia, aplasia) | 17 | 81* |
45,X Turner syndrome and variants | 16 | 73 |
Proximal hypospadias with uni-/bilateral undescended teste(s) | 14 | 70† |
47,XXY Klinefelter and variants | 15 | 68 |
Gonadal regression (anorchia) | 15 | 68 |
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome/Müllerian duct aplasia, renal aplasia, and cervicothoracic somite dysplasia (MURCS) | 14 | 67* |
46,XY bladder/cloacal anomalies | 13 | 62* |
46,XX bladder/cloacal anomalies | 13 | 62* |
Vaginal atresia | 13 | 62 |
Isolated micropenis | 12 | 57* |
Proximal hypospadias with descended testes | 10 | 50† |
Distal/mid-shaft hypospadias | 6 | 30† |
Undescended teste(s) | 6 | 27 |
Trauma | 0 | 0 |
one site selected “prefer not to answer” and therefore was not included in calculations
two sites selected “prefer not to answer” and therefore were not included in calculations
Note: Diagnoses/Phenotypes are listed identically to how they were displayed on the survey. Abbreviations not included above are as follows: MGD = Mixed Gonadal Dysgenesis; AMH = Anti- Müllerian Hormone; LH = Luteinizing Hormone